retatrutide lawsuit Lilly announces more next-gen obesity drug data, plans Q1 2027 FDA application Retatrutide, an experimental weight-loss drug,

To maintain your results, you will need to eat a healthy diet and exercise regularly

Dizziness Although a bit rare, some people feel dizzy and lightheaded right after treatment due to temporary changes in blood pressure

Perhaps the best single paper on this topic comes from Oprea and colleagues and was published in the British Journal of Anaesthesia in July 2025

The Rise of GLP-1s in Weight Loss Over the past year, GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have dramatically reshaped the conversation around weight loss

The peptide is available in the United States through 503A compounding pharmacies, which operate under state pharmacy board oversight and must compound pursuant to a valid patient-specific prescription [9]

it is supplied as a chemical reagent for laboratory use